TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SANA

Sana Biotechnology Inc

Healthcare · Biotechnology · —

2.90$ -0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SANA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– +182,500.0% +224.3% +87.0% +41.1% +57.2% -36.9% -17.7%
– +1,168.6% +289.3% +283.7% +71.4% -7.3% +6.0% -32.4%
– +27,800.0% +310.8% -62.2% -49.8% – – –
– – -41.5% +59.2% -23.0% +146.8% -106.4% –
– +5,592.0% -8.8% +25.1% -30.1% -4.0% +66.9% -97.2%
– +11,164.2% +187.5% -2.7% – -18.3% -89.9% -330.6%
– – – – -99.9% – – –
– – – – – – -71.3% +1,527.8%
– +389.3% +94.7% +45.0% -99.2% +544.1% +531.2% -35.6%
– +60.2% -10.4% +198.8% -155.3% – – –
– – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?